Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Catalytically Active UCH-L1 Is Required for MYC Driven B-Cell Lymphomagenesis

Tibor Bedekovics, PhD, Sajjad Hussain, PhD MSC, Paul J. Galardy, MD

Blood (2017) 130 (Supplement 1): 644.

https://doi.org/10.1182/blood.V130.Suppl_1.644.644

Published: 2017

Journal Articles

UCH-L1 Cooperates with BCL6 and Identifies Patients with Aggressive Germinal Center Diffuse Large B-Cell Lymphoma

Tibor Bedekovics, PhD, Sajjad Hussain, PhD, Andrew L Feldman, MD, Paul J. Galardy, MD

Blood (2015) 126 (23): 2673.

https://doi.org/10.1182/blood.V126.23.2673.2673

Published: 2015

Journal Articles

UCHL1 Is a Biomarker of Aggressive Multiple Myeloma Required for Disease Progression

Sajjad Hussain, PhD, Tibor Bedekovics, PhD, Marta Chesi, PhD, Leif Bergsagel, MD PhD, Paul J. Galardy, MD

Blood (2015) 126 (23): 2980.

https://doi.org/10.1182/blood.V126.23.2980.2980

Published: 2015

Journal Articles

UCH-L1 Is a Novel Regulator of mTOR Signaling That May Predict a Poor Response to mTOR Inhibition in Patients with B-Cell Lymphoma,

Sajjad Hussain, PhD, Steven C. Ziesmer, Andrew L. Feldman, MD, Stephen M. Ansell, MD, PhD, Paul J. Galardy, MD

Blood (2011) 118 (21): 3691.

https://doi.org/10.1182/blood.V118.21.3691.3691

Published: 2011

Journal Articles

UCH-L1, a Potent Oncogene That Drives the Development of B-Cell Lymphoma, Promotes Akt Signaling by Regulating Mtor Complex Assembly

Sajjad Hussain, PhD, Paul J. Galardy, MD

Blood (2010) 116 (21): 4182.

https://doi.org/10.1182/blood.V116.21.4182.4182

Published: 2010

Journal Articles

UCH-L1 Provides An Essential Survival Signal in Malignant B-Cells by Enhancing NF-κB Activation.

Sajjad Hussain, PhD, Paul J. Galardy, MD

Blood (2008) 112 (11): 3338.

https://doi.org/10.1182/blood.V112.11.3338.3338

Published: 2008

NARROW

Catalytically Active UCH-L1 Is Required for MYC Driven B-Cell Lymphomagenesis

UCH-L1 Cooperates with BCL6 and Identifies Patients with Aggressive Germinal Center Diffuse Large B-Cell Lymphoma

UCHL1 Is a Biomarker of Aggressive Multiple Myeloma Required for Disease Progression

UCH-L1 Is a Novel Regulator of mTOR Signaling That May Predict a Poor Response to mTOR Inhibition in Patients with B-Cell Lymphoma,

UCH-L1, a Potent Oncogene That Drives the Development of B-Cell Lymphoma, Promotes Akt Signaling by Regulating Mtor Complex Assembly

UCH-L1 Provides An Essential Survival Signal in Malignant B-Cells by Enhancing NF-κB Activation.

Email alerts

ASH Publications

American Society of Hematology

Catalytically Active UCH-L1 Is Required for MYC Driven B-Cell Lymphomagenesis

UCH-L1 Cooperates with BCL6 and Identifies Patients with Aggressive Germinal Center Diffuse Large B-Cell Lymphoma

UCHL1 Is a Biomarker of Aggressive Multiple Myeloma Required for Disease Progression

UCH-L1 Is a Novel Regulator of mTOR Signaling That May Predict a Poor Response to mTOR Inhibition in Patients with B-Cell Lymphoma,

UCH-L1, a Potent Oncogene That Drives the Development of B-Cell Lymphoma, Promotes Akt Signaling by Regulating Mtor Complex Assembly

UCH-L1 Provides An Essential Survival Signal in Malignant B-Cells by Enhancing NF-κB Activation.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only